Clinical Trials

12 enrolled

Depressive Disorder, Major

NCT05764928 2026-04-20

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

32 enrolled

Nonsquamous Nonsmall Cell Neoplasm of Lung

NCT07538804 2026-04-20

A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer

294 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

326 enrolled

Solid Tumors

NCT07444541 2026-04-16

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

84 enrolled

Pancreatic Neoplasms

NCT07529808 2026-04-15

ChefHat-001

164 enrolled

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07530666 2026-04-15

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

58 enrolled

Cachexia, Neoplasms

NCT07529717 2026-04-14

CRIUS-1

42 enrolled

Prostatic Neoplasms

NCT02802423 2026-04-13

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

44 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07509684 2026-04-13

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

190 enrolled

Advanced Solid Tumors

NCT07520006 2026-04-13

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

LymphoidOther hematologic neoplasm

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07514975 2026-04-09

First-In-Human Study of KHN922 for Injection

276 enrolled

Advanced Solid Tumors Cancer

NCT07519772 2026-04-09

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

200 enrolled

Lymphoid

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT07512583 2026-04-06

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

178 enrolled

Advanced Solid Tumor

NCT07510100 2026-04-03

FUMANBA-04

17 enrolled

Multiple Myeloma, Recurrence

NCT07468071 2026-04-02

KontRASt-R

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07508761 2026-04-02

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

52 enrolled

Advanced Solid Tumor

NCT07504263 2026-03-31

Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

66 enrolled

Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07431216 2026-03-30

A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression

68 enrolled

CNS

Glioblastoma

NCT07436728 2026-03-27

A Study of TAK-505 in Adults With Solid Tumors

151 enrolled

Malignant Solid Tumors

NCT07498725 2026-03-27

A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of LRK-4189 Alone and in Combination in Patients With Solid Tumors

120 enrolled

Tumor-Agnostic

Neoplasms

NCT06781125 2026-03-24

One Trial of JCXH-211 Intratumoral Injection Combined With Anti-PD-1 Antibody in Patients With Malignant Solid Tumors

72 enrolled

Malignant Solid Tumors

NCT07479485 2026-03-18

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

160 enrolled

Carcinoma, Hepatocellular

NCT07472647 2026-03-16

SYS6090 Combination Therapy in Advanced Lung Cancer

596 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT07468851 2026-03-13

A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy

180 enrolled

High-risk Non-muscle-invasive Bladder Cancer

NCT07469774 2026-03-13

BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

111 enrolled

Locally Advanced or Metastatic Solid Tumors

NCT07435038 2026-03-11

Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

120 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07459998 2026-03-10

SKB103 for Injection in Advanced Solid Tumors

277 enrolled

Advanced Solid Tumors

NCT07460375 2026-03-10

A Study to Evaluate Claudin 18.2-Directed ADC LCB02A in Advanced Solid Tumors

191 enrolled

Advanced Solid Tumors

NCT07453394 2026-03-06

QLS5132 Combination Therapy in Advanced Solid Tumors

GastrointestinalGynecologicThoracic

626 enrolled

Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms

NCT07454187 2026-03-06

To Evaluate the Safety of SG2918 in Patients With Relapsed/Refractory Multiple Myeloma

40 enrolled

Multiple Myeloma

NCT07346144 2026-03-04

ADePT

68 enrolled

CNS

Glioblastoma

NCT07445308 2026-03-03

The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG.

120 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT07439094 2026-02-27

A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07439653 2026-02-27

A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma

155 enrolled

Lymphoid

Lymphoma, B-Cell

NCT07336472 2026-02-25

A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma

360 enrolled

Multiple Myeloma

NCT07421856 2026-02-19

Phase I/II Study of SENL103 for Relapsed or Refractory Multiple Myeloma: A Multicenter, Open-Label, Single-Arm Trial.

24 enrolled

Multiple Myeloma

NCT07414927 2026-02-17

A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy

48 enrolled

Small Cell Lung Carcinoma

NCT07391566 2026-02-06

LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation

99 enrolled

Colorectal Neoplasms

NCT07387926 2026-02-04

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

LymphoidOther hematologic neoplasm

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07380386 2026-02-02

SKB105 for Injection in Advanced Solid Tumors

256 enrolled

Advanced Solid Tumors

NCT07374419 2026-01-28

PARP7

178 enrolled

Neuroleptic Malignant Syndrome

NCT07367529 2026-01-26

A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection

465 enrolled

Advanced Lung Cancer

NCT07131722 2026-01-23

Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II

25 enrolled

CNS

Neurofibromatosis 2

NCT07364422 2026-01-23

To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer

49 enrolled

Stomach Neoplasms

NCT06906471 2026-01-22

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

10 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07355231 2026-01-22

GuidedRT

10 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07358585 2026-01-22

A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer

126 enrolled

Colonic Neoplasms

NCT07357220 2026-01-21

A Study of AK112 in Combination With VG2025 in Colorectal Cancer With Liver Metastases

72 enrolled